At the Society for Cardiovascular Angiography and Interventions’ (SCAI) Leadership Boot Camp, catheterization laboratory teams will learn skills they need to thrive while tackling high-pressure, high-stakes challenges.

The FDA granted Abiomed premarket approval for its Impella 2.5 heart pump for use during high-risk PCIs. The device provides temporary ventricular support.

Boston Scientific’s implantable Watchman Left Atrial Appendage Closure Device finally won FDA approval to become an option to long-term warfarin therapy for high-risk patients with nonvalvular atrial fibrillation.

Former Intel executive Sean Maloney set off on a 5,000-mile cycling quest March 22 to raise awareness about stroke prevention. His Heart Across America campaign is a three-month fundraising trek from Palo Alto, Calif., to New York City.

Sometimes eliminating a drug may be the best way to care for a dying patient. Findings comparing continued and terminated statin therapy in palliative care patients found those who discontinued statins experienced improved quality of life with no significant increase in risk of death.

Janssen Pharmaceuticals acquired a university spinout company that develops an antithrombin antibody, adding another potential therapy to its portfolio.

The FDA approved a pacemaker system that allows patients with single-chamber pacemakers to undergo full-body cardiac or thoracic MRI scans.

The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.